Comparative analysis of adenovirus, mRNA, and protein vaccines reveals context-dependent immunogenicity and efficacyJCI INSIGHTIF6.12025-11-100PRE
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibodyJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-12-0138OAAI
Cross-protection by SARS vaccines is improved by booster vaccinationJOURNAL OF IMMUNOLOGYIF3.42022-05-010PRE
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunitySCIENCE IMMUNOLOGYIF16.32021-12-2424OA
未登录.png){kind=icon}
未登录
